" In addition to paxalisib, the other therapies involved will initially include ONC201, manufactured by Oncoceutics, Inc, and panobinostat, manufactured by SecuraBio, Inc. The study is expected to open initially in the United States and will then expand to other countries during CY2021. "
I am willing to bet that they will trial Cantrixil one day, what's the bet?
" In addition to paxalisib, the other therapies involved will...
Add to My Watchlist
What is My Watchlist?